ANZUP 2025 Conference Review
Sleep Watch 1 – Oveporexton, an oral orexin receptor 2-selective agonist, in Narcolepsy Type 1
IBD Watch 12 – New therapeutic targets for IBD; is 2025 the year for IL23-p19 in Australia?
Gastroenterology Watch 29 – Pouchitis assessment tool
Endocrinology Watch 13 – Elinzanetant for vasomotor symptoms from endocrine therapy for breast cancer
Cardiology Watch 23 – post-ACS residual CV risk: what’s the approach to TG in 2025?
